Octagon Research, a provider of software and services to the life sciences industry, today announced the release of a global document authoring template suite.
Octagon Research Solutions, Inc. Releases startingpoint® 3.2Global Submission Document Authoring Template Suite Includes Over 230 Templates
(WAYNE, PA, November 7, 2008) - CEO & Chairman Jim Walker of Octagon Research Solutions, Inc., a pioneer and leading provider of breakthrough software and services to the life sciences industry, today announced the release of StartingPoint® 3.2. With over 120 clients, Octagon’s StartingPoint global document authoring template suite has proven to be a preferred solution for organizations seeking to standardize their authoring processes in support of electronic submissions.
Some of the new enhancements to StartingPoint 3.2 include:
John Lawrie, vice president, Process Solutions at Octagon Research Solutions, Inc. noted, “Evolving global submission standards are adding complexity to the already challenging submission authoring process. Since StartingPoint was first released in 2003, we have worked closely with our internal experts and clients to continue to enhance our suite of templates to support this changing environment. This new release will provide greater flexibility for authors and improve document quality.”
“Octagon’s Process and Regulatory Consultants have been dedicated to the development of this latest version of StartingPoint and their practical expertise is infused into every template,” commented John Rogers, director, Process Solutions. “Our entire portfolio of templates demonstrates the unique combination of domain expertise integrated with enabling technology that is so critical to submission document authoring and that is always associated with Octagon’s solutions.”
To see a demonstration of StartingPoint 3.2 or to learn more about Octagon’s integrated product and service offerings, please contact Octagon Research Solutions, Inc. at (610)-535-6500 or www.octagonresearch.com.
About Octagon Research Solutions, Inc.
Octagon is a pioneer and leading provider of breakthrough software and services to the life sciences industry. Octagon’s eCTD and CDISC solutions provide the people, process and technology required to optimize drug development from data collection to submission. Our regulatory, clinical, process and software offerings provide a unique combination of deep domain knowledge, cross-functional electronic submission expertise, a holistic process approach, and integrated solutions. Octagon is headquartered in Wayne, PA, with European headquarters in Berkhamsted, UK. Octagon’s EDC Operations are located in Mountain View, CA. For more information please visit www.octagonresearch.com.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.